Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors.

Article Details

Citation

Liu D, Offin M, Harnicar S, Li BT, Drilon A

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors.

Ther Clin Risk Manag. 2018 Jul 20;14:1247-1252. doi: 10.2147/TCRM.S147381. eCollection 2018.

PubMed ID
30050303 [ View in PubMed
]
Abstract

Entrectinib is a potent small-molecule tyrosine kinase inhibitor that targets oncogenic rearrangements in NTRK, ROS1, and ALK. The consolidated results of 2 Phase I trials demonstrated activity in tyrosine kinase inhibitor-naive patients along with substantial intracranial activity. In ROS1-rearranged lung cancers, entrectinib results in durable disease control and prolonged progression-free survival. The drug is well tolerated and has a safety profile that includes adverse events mediated by on-target tropomyosin-related kinase A/B/C inhibition.

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
EntrectinibBDNF/NT-3 growth factors receptorProteinHumans
Unknown
Inhibitor
Details
EntrectinibHigh affinity nerve growth factor receptorProteinHumans
Yes
Inhibitor
Details
EntrectinibNT-3 growth factor receptorProteinHumans
Yes
Inhibitor
Details
EntrectinibProto-oncogene tyrosine-protein kinase ROSProteinHumans
Yes
Inhibitor
Details
Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
EntrectinibCytochrome P450 3A4ProteinHumans
Unknown
Substrate
Details
Drug Interactions
DrugsInteraction
Entrectinib
Phenytoin
The metabolism of Entrectinib can be increased when combined with Phenytoin.
Entrectinib
Pentobarbital
The metabolism of Entrectinib can be increased when combined with Pentobarbital.
Entrectinib
Carbamazepine
The metabolism of Entrectinib can be increased when combined with Carbamazepine.
Entrectinib
Mitotane
The metabolism of Entrectinib can be increased when combined with Mitotane.
Entrectinib
Primidone
The metabolism of Entrectinib can be increased when combined with Primidone.